MOG and myeloid sarcoma: The specific mechanisms for antibodies in demyelination are not totally understood, but IgG1-producing clones have been generated from MS patients and the amount of demyelination correlated positively with the complement C9 protein following disease induction with anti-MOG IgG1 antibodies [33].